Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life

NCT07655128 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

87

Enrollment

OTHER

Sponsor class

Conditions

HIV -1 Infection

Interventions

DRUG: Broadly neutralizing antibody (bNAb) ePGT121v1-LS
DRUG: Saline (0.9% NaCl)

Sponsor

Hospital Universitario 12 de Octubre

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]